Drugs Made In America Acqustn II Corp (DMII) Stock Price & News

DMII:NASDAQ

Drugs Made In America Acqustn II Corp

$10.17

-0.05%

(-0.0050) 1D

Sep 18, 4:00:00 PM GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for DMII...

Open

$10.18

High

$10.18

Low

$10.17

Mkt. cap

647.51M

Avg. vol.

54.29K

Volume

153.56K

P/E ratio

12.58

52-wk high

$10.21

52-wk low

$9.87

EPS

$0.81

Shares outstanding

63.70M

Open

$10.18

High

$10.18

Low

$10.17

Mkt. cap

647.51M

Avg. vol.

54.29K

Volume

153.56K

P/E ratio

12.58

52-wk high

$10.21

52-wk low

$9.87

EPS

$0.81

Shares outstanding

63.70M

Related stocks

CCXI

Churchill Capital Corp XI

$12.90

+6.83%

CXII

Churchill Capital Corp XII

$10.64

-0.75%

EVAC

EQV Ventures Acquisition Ord Shs Class A

$10.30

0.00%

BCSF

Bain Capital Specialty Finance Inc

$11.09

-1.86%

News stories

From web sources and news partners

CarePlus VietNam

2 days ago

Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17 - Quality ETF

CarePlus VietNam

1 month ago

Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest Trading - Profitability Factor

CarePlus VietNam

1 month ago

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest Session - PCR Divergence

About Drugs Made In America Acqustn II Corp

CEO-

Employees-

Founded2024

HeadquartersFort Lauderdale, Florida, United States

SectorCapital market

Website-

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	155.51K	235.47K	132.03K	112.23K
Operating expense	155.51K	1.05M	102.03K	112.23K
Total operating expenses	155.51K	1.05M	102.03K	112.23K
Operating income	-155.51K	-1.05M	-102.03K	-112.23K
Other non operating income	-	-	-	-
EBT including unusual items	-46.16K	4.33M	4.34M	4.40M
EBT excluding unusual items	-46.16K	3.78M	4.34M	4.40M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-46.16K	4.33M	4.34M	4.40M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	109.36K	4.82M	4.44M	4.51M
Interest expense	-	-	-	-
Net interest expenses	109.36K	4.82M	4.44M	4.51M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Ask anything